-4.25% for Canopy Growth stock as shares continue to trade below long-term averages

Traders Union
All News
Financial News
Canopy Growth drops 4.25% today

Highlights

Canopy Growth's Q4 2026 net revenue surged, with Canadian medical up 27% and international markets up 68%, reflecting robust segment growth.
The MTL Cannabis acquisition solidified Canopy's lead in Canadian medical cannabis, while enhanced liquidity reached C$131.3 million despite continued share price weakness.
CGC/USD trades below major moving averages with sustained bearish momentum; expected price range is $0.90–$0.99, downside risk remains dominant.

Revenue gains and acquisition bolster liquidity amid weak price action

On June 15, 2026, Canopy Growth Corporation reported its fourth quarter and full-year 2026 financial results, providing detailed insight into operational trends and recent performance. Q4 saw net revenue from Canada medical cannabis rise by 27% and international markets by 68%, while full-year gains across Canada adult-use and medical segments reflected continued market penetration. The completion of the MTL Cannabis acquisition strengthened Canopy Growth's leadership in Canadian medical cannabis by revenue, with an improved net cash position of C$131.3 million enhancing liquidity for the period, though price action has remained under broader selling pressure.

Bearish momentum confirmed as oversold signals and resistance converge

CGC/USD has slipped below the MA-20 ($1.00), MA-50 ($1.01), and remains well below the MA-200 ($1.19). The Ichimoku Kijun at $0.99 acts as immediate resistance, and support is found near $0.90. MACD is currently on a Sell signal, the ADX is neutral, and RSI at 33.15 confirms oversold conditions alongside Stoch RSI and CCI. Intraday, BBP signals dominant selling, while the Awesome Oscillator continues to indicate a bearish tone. Overall, oscillators and momentum indicators align with ongoing downward momentum, confirming a technically pressured environment.

Downside risk elevated as breakout odds remain minimal short term

Over the next 2–3 trading days, the expected price range for CGC/USD is $0.90–$0.99, reflecting a typical volatility band relative to current levels. The probability of an upward breakout is very low, while further downside risk is considered very high in the short term. The baseline scenario is sideways movement within this range, with a bullish reversal requiring a move above immediate resistance at $0.99. Should the price break below $0.90, a bearish continuation is likely to develop.

Viktoras Karapetjanc, expert at Traders Union, notes that Canopy Growth’s latest results highlight strong revenue growth and an improved cash position, confirming constructive fundamentals despite current price weakness. He believes recent operational gains enhance long-term prospects, though market sentiment and technicals still favor a defensive near-term stance. Karapetjanc sees significant downside risk unless $0.99 is reclaimed, but emphasizes that the liquidity buffer and narrowing losses are encouraging signals for patient investors. "If Canopy Growth sustains its financial improvements, any stabilization above $0.99 could spark renewed positive momentum."

Earlier, analysts noted that Canopy Growth was exhibiting mixed momentum with persistent downside risks and lacked strong directional cues. The current technical data and latest financials reinforce a challenging environment for the stock, with traders advised to monitor support at $0.90 as a breach could trigger an extended bearish move.

Source of Data: CGC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.